As of late August 2017, The Ordinary’s portfolio of retinoids has been extended based on valuable consumer feedback and, as part of these introductions, Advanced Retinoid 2% has been renamed to Granactive Retinoid 2% Emulsion to align with the new naming direction of the extended range. The formula continues to offer an emulsion of 2% of the same advanced retinoid complex.
This formulation combines two forms of next-generation retinoid actives:
a) A 2% concentration of Granactive Retinoid™ which is a complex of solubilized Hydroxypinacolone Retinoate (HPR). HPR is a highly-advanced form of retinoid which is, in fact, a non-prescription ester of all-trans direct retinoic acid that offers a multi-fold better effect against signs of aging than retinol, retinyl palmitate and nearly all other forms of non-prescription retinoid;
b) A sustained-delivery form of pure retinol in a protective capsule system which supports both the delivery and the effect of Granactive Retinoid™.
Both forms of retinoid used avoid the irritation associated with retinoids (including retinol) use while delivering better visible results against signs of aging.
This product uses next-generation retinoid active technologies which have been shown to achieve better reduction in signs of aging than retinol without irritation. These technologies cannot be compared directly with retinol itself in terms of concentration because they include a different retinoid molecule, in a similar way that Retinol cannot be compared with Retinoic Acid in terms of concentration. If you have interest in a retinol product, please refer to our Retinol portfolio above which products contain pure retinol and cost less since many retinol technologies cost less than their next-generation counterparts like Granactive Retinoid™.
The Ordinary’s extended portfolio of retinoids includes the following formulations:
While the new offerings of Granactive Retinoid™ in Squalane offer a very-light-weight solution for better compatibility with several steps in a regimen, the existing formula continues to be a creamy hydrating emulsion for those who prefer this format.
Caution: Retinoids can make the skin more sensitive to UV radiation. Sun protection is particularly important when using retinoids. This product must not be used in conjunction with other retinoids including retinol or retinoic acid. This product is not a treatment for acne. Acne-prone skin may experience a temporary increase in acne during the first few weeks of using any form of retinoid including those used in this formulation.
Note: When pregnant or breastfeeding, it is recommended to avoid any skincare products containing retinoids such as formulations with Granactive Retinoid™ or Retinol.
Granactive Retinoid™ is a trademark of Grant Industries. Neither DECIEM nor The Ordinary is affiliated with Grant Industries.
Apply a small amount to face in the PM as part of your skincare regimen, after water-based serums but before heavier treatments. Do not use with other retinoid treatments. Avoid unprotected solar exposure. If irritation occurs, cease use and consult a physician. Use only as directed on unbroken skin. Patch testing prior to use is advised. Keep out of reach of children. Refrigerate after opening.See how to combine multiple formulations from The Ordinary in a single regimen
Patch tests are an easy way to help predict if you may experience a negative initial reaction to a new product. It is recommended to perform a patch test before incorporating any new product into your regimen. We have outlined a general method for conducting your own patch test below based on the type of product.
- Apply a small amount of the product onto a clean area of skin on the upper forearm.
- Keep the area dry.
- If the product has a specified duration of use, rinse off after this time has elapsed. Otherwise rinse off after 24 hours.
- If any redness, burning, itching, blistering or irritation is observed at any time throughout the test, do not use the product.
Reviews
There are no reviews yet.